Bio-Gene Technology launches key safety study for Flavocide
Bio-Gene Technology (ASX:BGT) has commenced a critical acute neurotoxicity study for its flagship nature-derived insecticide, Flavocide.

Founder and CEO of Grafa, leading the company's vision to democratise financial data and empower investors with innovative tools.
Bio-Gene Technology (ASX:BGT) has commenced a critical acute neurotoxicity study for its flagship nature-derived insecticide, Flavocide.
Auravelle Metals (ASX:AUV) has achieved a pivotal operational milestone at its 100%-owned Crown Gold Project, announcing the completion of a second heritage survey.
BrainChip (ASX:BRN) announced the initiation of its AKD2500 custom silicon development project.
St George Mining (ASX:SGQ) has secured a financial boost for its Araxá Niobium and Rare Earths Project.
Australian workforce solutions powerhouse PeopleIN (ASX:PPE) appointed co-founder and industry veteran Tom Reardon as its new CEO and Managing Director.
Kremlin insiders have reportedly drafted a bold proposal to re-embrace the US dollar as part of a sweeping economic reset pitched to a potential Donald Trump administration.
GQG Partners (ASX:GQG) has capped off its 2025 fiscal year with a resilient financial performance, navigating a complex market landscape to deliver growth across its key metrics.
Figure Technology Solutions (NASDAQ:FIGR) signaled a massive acceleration in the adoption of blockchain-based lending, reporting that its consumer loan marketplace volume more than doubled in the final quarter of 2025.
Dauch (NYSE:DCH), the newly rebranded automotive supplier formerly known as American Axle & Manufacturing, signaled a massive scale-up for 2026 after closing its transformational acquisition of Dowlais Group.
Sensient Technologies (NYSE:SXT) reported a 4.5% increase in fourth-quarter revenue, fueled by a surge in new business wins that helped offset the heavy lifting of a multi-year corporate restructuring.